Inflammatory events in endometrial adenocarcinoma
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Endometrial adenocarcinoma is the most common gynaecological malignancy in western countries. Many of the established risk factors for developing endometrial cancer are associated with excess exposure to oestrogen unopposed by progesterone. These include nulliparity, late onset of the menopause, post-menopausal hormone replacement therapy and obesity. However, a number of risk factors also promote inflammation, another feature proposed to influence cancer development. The human cycling endometrium undergoes regular and cyclical episodes of inflammation. Moreover, hormonal and genetic changes that occur early in the development of endometrial adenocarcinoma can exacerbate the local inflammatory environment. Via alterations in the expression of local mediators and immune cell function, these may contribute to the development of endometrial cancer. This review discusses the contribution of inflammation to the initiation and progression of endometrial adenocarcinoma. Manipulation of inflammatory pathways may therefore represent a therapeutic target in endometrial adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
Barrientos, S., Stojadinovic, O., Golinko, M. S., Brem, H., & Tomic‐Canic, M. (2008) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2008.00410.x · Cited by 3,583 · cited 2×
“These factors are also all produced to orchestrate wound healing in inflammatory situations (Barrientos et al. 2008).”
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272 · cited 1×
“…of inflammatory COX2 and prostaglandins has been correlated with tumour growth and angiogenesis in several cancer types including prostate, pancreatic and colon cancer (Tsujii et al. 1998, Molina et al. 1999, Jain et al. 2008) and endometrial adenocarcinoma (Tong et al. 2000, Jabbour et al. 2001).”
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Couse, J. F., & Korach, K. S. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0370 · Cited by 2,045 · cited 1×
“Studies using mice with targeted deletion of the ESR1 gene have reported that this subtype plays an essential role in uterine cell proliferation and expression of the progesterone receptor gene (reviewed in Couse & Korach (1999)).”
BackgroundDifferential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy
Lin, E. Y., Nguyen, A. V., Russell, R. G., & Pollard, J. W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.727 · Cited by 1,594 · cited 2×
“…tumour progression and metastasis rate were www.endocrinology-journals.org Downloaded from Bioscientifica.com at 12/08/2018 03:31:17AM via free access demonstrated, and the re-introduction of macrophages enabled tumour progression to rapidly catch up with control counterparts (Lin et al. 2001).”
BackgroundReeves, G. K., Pirie, K., Beral, V., Green, J., Spencer, E., & Bull, D. (2007) · BMJ · doi:10.1136/bmj.39367.495995.ae · Cited by 1,507 · cited 1×
“Notably, a high body mass index increases the risk of developing endometrial cancer, and these patients have a poorer prognosis (Bergstrom et al. 2001, Gates et al. 2006, Rieck & Fiander 2006, Reeves et al. 2007).”
BackgroundThe Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222 · cited 2×
“A number of C-X-C chemokines are angiogenic (Strieter et al. 1995) and mitogenic (Wang et al.”
BackgroundMichnovicz, J. J., Hershcopf, R. J., Naganuma, H., Bradlow, H. L., & Fishman, J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152101 · Cited by 658
Endocrine regulation of menstruation
Jabbour, H. N., Kelly, R. W., Fraser, H. M., & Critchley, H. O. D. (2006) · Endocrine Reviews · doi:10.1210/er.2004-0021 · Cited by 588 · cited 2×
“This results in a decline in progesterone and menses occur ( Jabbour et al. 2006).”
BackgroundSelf-citationEGF and TGF‐α in wound healing and repair
Schultz, G., Clark, W., & Rotatori, D. S. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240450407 · Cited by 357 · cited 13×
“Neutrophils at this stage of the cycle are observed adjacent to the vasculature, and produce VEGF, and therefore may be involved in vascular remodelling (Gargett et al. 2001).”
BackgroundInfluentialCritchley, H. O. D., Brenner, R. M., Henderson, T. A., Williams, K., Nayak, N. R., Slayden, O. D., Millar, M. R., & Saunders, P. T. K. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7317 · Cited by 210
Self-citationCampbell, E. L., Louis, N. A., Tomassetti, S. E., Canny, G. O., Arita, M., Serhan, C. N., & Colgan, S. P. (2007) · The FASEB Journal · doi:10.1096/fj.07-8473com · Cited by 205 · cited 1×
“These perform functions such as promoting the clearance of apoptotic leukocytes, and preventing further chemokine expression by these cells (Campbell et al. 2007).”
BackgroundThe endocrinology of menstruation – a role for the immune system
Critchley, H. O. D., Kelly, R. W., Brenner, R. M., & Baird, D. T. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01432.x · Cited by 203 · cited 2×
“…of ESRs in normal premenopausal endometrium has been well documented with the expression of ESR1 being intense in both glands and stroma during the proliferative, oestrogen-dominant phase but reduced in the secretory phase following the post-ovulatory rise in progesterone (Critchley et al. 2001b).”
BackgroundAlexander, I. E., Clarke, C. L., Shine, J., & Sutherland, R. L. (1989) · Molecular Endocrinology · doi:10.1210/mend-3-9-1377 · Cited by 109
Lavergne, E., Combadière, C., Iga, M., Boissonnas, A., Bonduelle, O., Maho, M., Debré, P., & Combadiere, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3755 · Cited by 89 · cited 1×
“The cytotoxic nature of lymphocytes has already been discussed, and both neutrophils and macrophages have been shown in mouse models of different cancer types to reduce tumour growth (Lee et al. 2000, Lavergne et al. 2004).”
Background
Cited by
New concepts for an old problem: the diagnosis of endometrial hyperplasia
Sanderson, P. A., Critchley, H. O. D., Williams, A. R. W., Arends, M. J., & Saunders, P. T. K. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw042 · Cited by 323
Self-citationGibson, D. A., & Saunders, P. T. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.026 · Cited by 107
Self-citationA role for lipoxin A4 as an anti-inflammatory mediator in the human endometrium
Macdonald, L. J., Boddy, S. C., Denison, F. C., Sales, K. J., & Jabbour, H. N. (2011) · Reproduction · doi:10.1530/rep-11-0021 · Cited by 65
“2007), endometrial cancer (Wallace et al. 2010), endometriosis (Ryan et al.”
BackgroundSelf-citationWhirledge, S., Xu, X., & Cidlowski, J. A. (2013) · Biology of Reproduction · doi:10.1095/biolreprod.113.111054 · Cited by 44
“Furthermore, as a cell line derived from endometrial carcinoma, a pathology linked to the inflammatory response for both its initiation and progression, unique glucocorticoid gene targets involved in the inflammatory response may be implicated as both therapeutic targets and agents involved in the biology of uterine e…”
Background
Metadata
- Authors
- Wallace, A. E., Gibson, D. A., Saunders, P. T. K., & Jabbour, H. N.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2010-04-20
- Volume
- 206
- Issue
- 2
- Pages
- 141-157
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W1980307905
- Cited by
- 127
- References
- 18
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.